DeepCardio's research and development to predict the risk of all cardiac diseases using only an ECG test is ongoing.
Currently, 3 products are commercially available and 8 products have completed development and are undergoing pilot testing.
SmartECG-CV Risk
SmartECG-CV Risk is an AI ECG solution that analyzes ECG data to estimate an AI-derived cardiac age and compares it with the patient's actual age to assess cardiovascular risk.
Standard ECG Test
(10 Seconds)
Since it uses the same ECG procedure already in practice, introducing SmartECG adds no additional workload.
SmartECG AI Analysis
After a standard 10-second 12-lead ECG test, the SmartECG analysis engine processes
the generated digital data (XML) to analyze subtle signal patterns.
Cardiovascular Risk Assessment
The AI cardiac age estimate is compared to the patient's actual age
to deliver a cardiovascular risk score.
The existing workflow is preserved, meaning there is no additional burden from adding an AI-powered analysis.
SmartECG-CV Risk Analysis
Based on an AI model trained on large-scale ECG data, SmartECG-CV Risk analyzes subtle electrical changes in the ECG.
Through this analysis, the AI estimates a cardiac age from the ECG, and research has shown that the greater the gap between the AI-estimated age and the actual age, the higher the cardiovascular risk.
Data-Driven
Trained on large-scale ECG datasets
Validated Across Diverse Datasets
Efficacy validated using National Health Insurance data and UK Biobank data as part of a government research initiative
Academic Recognition
Award from the European Heart Rhythm Association (EHRA)
SmartECG
Integrated Analysis Results
SmartECG delivers multiple analysis results from a single ECG test, all consolidated in one screen.
Upcoming Analyses to Be Integrated:
sigCAD · ACS · HFmrEF · HCMP · Fabry and more
Products currently under regulatory approval will be integrated into the service sequentially upon completion of required approvals.
AF Risk Analysis Results
Indicator for likelihood of atrial fibrillation
CV Risk Cardiac Age-Based
Analysis Results
Cardiac age-based cardiovascular risk indicator
EF-Related Analysis Results
Left ventricular ejection fraction (EF) indicator
Clinical Value
Conventional Cardiac Health Assessment
- Difficult to explain cardiac health status in an intuitive way
- Assessment focused on current symptoms or single test results
- Difficult to communicate risk levels to patients
- Focus on management after an abnormality is found, rather than prevention
With SmartECG-CV Risk
- Intuitively explains cardiac health status
based on AI-estimated cardiac age - Provides a reference indicator for long-term cardiovascular risk based on ECG
- Improves patient understanding by comparing
AI cardiac age with actual age - Enables prevention-centered cardiovascular disease management strategies
SmartECG
SmartECG-CV Risk estimates cardiac age from ECG data, providing the likelihood of mid-to-long-term cardiovascular events as a risk indicator.
It is particularly effective for communicating cardiovascular risk intuitively to asymptomatic patients and health checkup recipients, making it a valuable tool for early intervention and preventive management.
AI ECG Testing Procedure
ECG Test
Standard 10-second ECG test performed in outpatient or health checkup settings
Review CV Risk Results
Review cardiovascular risk indicators analyzed by SmartECG
Risk-Based Patient Communication
Explain current cardiac health status and long-term cardiovascular risk to the patient
Clinical Decision
Determine whether further testing is needed and recommend lifestyle improvements for prevention